Zhongyu Wang from San Francisco, CA, age 53

Resumes

Software Engineer

View page

Location:

San Francisco, CA

Industry:

Internet

Work:

Figma
Software Engineer
Uber Nov 2, 2015 - Feb 2017
Senior Software Engineer Ii
Google Jun 2015 - Oct 2015
Software Engineer Iii
Google Oct 2013 - Oct 2015
Software Engineer Ii

Education:

Peking University 2009 - 2013
Bachelors, Computer Science, Psychology

Skills:

Java
C++
C
Algorithms
Linux
Android Development
Ios Development
Html
Objective C
Javascript
User Interface Design
Mysql
Swift
Swift

Interests:

Science and Technology
Social Services

Languages:

Chinese

Certifications:

Preventing Workplace Harassment

Publications

Us Patents

Heterocyclic Gpr40 Modulators

View page

US Patent:

8003648, Aug 23, 2011

Filed:

Nov 5, 2009

Appl. No.:

12/613418

Inventors:

Hilary Beck - San Carlos CA, US
Paul Dransfield - San Francisco CA, US
Zice Fu - Foster City CA, US
Jonathan B. Houze - San Mateo CA, US
XianYun Jiao - Belmont CA, US
Todd J. Kohn - San Mateo CA, US
SuJen Lai - Burlingame CA, US
Jinqian Liu - Palo Alto CA, US
Jiwen Liu - Foster City CA, US
Zhihua Ma - San Mateo CA, US
Julio C. Medina - San Carlos CA, US
Michael J. Schmitt - Oakland CA, US
Rajiv Sharma - Fremont CA, US
Wang Shen - San Mateo CA, US
Marc Vimolratana - San Mateo CA, US
Yingcai Wang - Millbrae CA, US
Zhongyu Wang - Ewing NJ, US

Assignee:

Amgen Inc. - Thousand Oaks CA

International Classification:

A61K 31/498
A61K 31/42
A61K 31/426
A61K 31/4245
A61K 31/443
C07D 261/06
C07D 277/22
C07D 271/06
C07D 413/02
C07D 241/36
A61P 3/10
A61P 9/00

US Classification:

514250, 514378, 514365, 514364, 514340, 548247, 548203, 548131, 5462721, 544344

Abstract:

The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I:.

Bicyclic Carboxylic Acid Derivatives Useful For Treating Metabolic Disorders

View page

US Patent:

20070244155, Oct 18, 2007

Filed:

Mar 13, 2007

Appl. No.:

11/717945

Inventors:

Rajiv Sharma - Fremont CA, US
Michelle Akerman - San Francisco CA, US
Mario Cardozo - San Francisco CA, US
Jonathan Houze - San Mateo CA, US
Jinquian Liu - Palo Alto CA, US
Jiwen Liu - Foster City CA, US
Zhihua Ma - San Mateo CA, US
Julio Medina - San Carlos CA, US
Michael Schmitt - Oakland CA, US
Ying Sun - Albany CA, US
Yingcai Wang - Fremont CA, US
Zhongyu Wang - San Mateo CA, US
Liusheng Zhu - Burlingame CA, US

Assignee:

AMGEN INC. - Thousand Oaks CA

International Classification:

A61K 31/4704
A61K 31/405
A61K 31/366
A61K 31/353
A61K 31/192

US Classification:

514312000, 514419000, 514457000, 514450000, 514569000, 546157000, 548495000, 549285000, 549355000, 514456000, 562467000, 549405000

Abstract:

Compounds having the general formula I and/or the general formula II are useful, for example, for treating metabolic disorders in a subject where the variables are provided herein. Compositions and methods for using the compounds for preparing medicaments and for treating metabolic disorders such as, for instance, type II diabetes are disclosed.

Heterocyclic Gpr40 Modulators

View page

US Patent:

20080090840, Apr 17, 2008

Filed:

Sep 6, 2007

Appl. No.:

11/900006

Inventors:

Hilary Beck - San Carlos CA, US
Paul Dransfield - San Francisco CA, US
Zice Fu - Foster City CA, US
Jonathan Houze - San Mateo CA, US
Xian Yun Jiao - Belmont CA, US
Todd Kohn - San Mateo CA, US
SuJen Lai - Burlingame CA, US
Jinqian Liu - Palo Alto CA, US
Jiwen Liu - Foster City CA, US
Zhihua Ma - San Mateo CA, US
Michael Schmitt - Oakland CA, US
Rajiv Sharma - Fremont CA, US
Wang Shen - San Mateo CA, US
Marc Vimolratana - San Mateo CA, US
Yingcai Wang - Fremont CA, US
Zhongyu Wang - San Mateo CA, US

Assignee:

Amgen Inc. - Thousand Oaks CA

International Classification:

A61K 31/41
A61K 31/42
A61K 31/44
A61K 31/4965
A61P 43/00
C07D 241/36
C07D 261/06
C07D 271/06
C07D 277/30
C07D 413/00

US Classification:

514255050, 514340000, 514364000, 514365000, 514378000, 544344000, 546272100, 548131000, 548204000, 548247000

Abstract:

The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: where the definitions of the variables are provided herein. The present invention also provides compositions that include, and methods for using, the compounds in preparing medicaments and for treating metabolic disorders such as, for example, type II diabetes.

Spirocyclic Gpr40 Modulators

View page

US Patent:

20110190330, Aug 4, 2011

Filed:

Oct 13, 2009

Appl. No.:

13/119951

Inventors:

Sean P. Brown - San Francisco CA, US
Paul Dransfield - San Francisco CA, US
Xiaohui Du - Belmont CA, US
Zice Fu - Foster City CA, US
Jonathan Houze - San Mateo CA, US
XianYun Jiao - Belmont CA, US
Sujen Lai - Burlingame CA, US
Jiwen Liu - Foster City CA, US
Zhihua Ma - Foster City CA, US
Julio C. Medina - San Carlos CA, US
Vatee Pattaropong - Burlingame CA, US
Wang Shen - San Mateo CA, US
Marc Vimolratana - San Francisco CA, US
Yingcai Wang - Millbrae CA, US
Zhongyu Wang - Ewing NJ, US
Ming Yu - Foster City CA, US
Liusheng Zhu - Foster City CA, US

Assignee:

AMGEN INC. - Thousand Oaks CA

International Classification:

A61K 31/4418
C07C 69/757
C07C 62/34
C07D 213/64
C07D 249/08
C07D 311/96
C07D 217/24
C07D 231/12
A61K 31/216
A61K 31/192
A61K 31/4196
A61K 31/352
A61K 31/415
A61K 31/426
A61P 3/10

US Classification:

514278, 560 56, 562466, 546 15, 5482694, 549345, 546 18, 5483575, 514510, 514569, 514383, 514454, 514406, 514365

Abstract:

The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula IA, IB, I′A or I′B:where the definitions of the variables are provided herein. The present invention also provides compositions that include, and methods for using, the compounds in preparing medicaments and for treating metabolic disorders such as, for example, type II diabetes.